A. E. Karpov
Research Subjects
A. E. Karpov has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anna S. Artemyeva
N. N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - E. Yu. Fedorutseva
National Research Tomsk State University
2 shared publications - Elizaveta A. Prosekina
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Valeriia A. Shapkina
Department of Pathology, Laboratory of the Microangiopathic Mechanisms of Atherogenesis, Saint Petersburg State University, Saint Petersburg 199034, Russia
2 shared publications Е. Ю. Федоруцева
ФГАОУ ВО «Национальный исследовательский Томский государственный университет
1 shared publication
Latest Publications
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 60-67
DDAH1 protein: biological functions, role in carcinogenesis processes
Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) is an essential enzyme capable of degrading asymmetric dimethylarginine, which is an endogenous inhibitor of nitric oxide synthase. Increased expression of DDAH1 and subsequent increased NO production are associated with carcinogenesis. In particular, DDAH1 is involved in the creation of a vascular network by tumor cells, vasculogenic mimicry, which is closely associated with tumor progression and poor patient prognosis. This is the reason why DDAH1 may be a potential therapeutic target for the treatment of cancer.
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 60-67
DDAH1 protein: biological functions, role in carcinogenesis processes
Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) is an essential enzyme capable of degrading asymmetric dimethylarginine, which is an endogenous inhibitor of nitric oxide synthase. Increased expression of DDAH1 and subsequent increased NO production are associated with carcinogenesis. In particular, DDAH1 is involved in the creation of a vascular network by tumor cells, vasculogenic mimicry, which is closely associated with tumor progression and poor patient prognosis. This is the reason why DDAH1 may be a potential therapeutic target for the treatment of cancer.
- Open Access
- 15 January 2025
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 12 (1) , 14-30
The balance between deception and adaptation: vasculogenic mimicry as a tumor survival strategy
Vasculogenic mimicry is a unique process through which tumor cells imitate normal vascular endothelial cells to secure access to the blood flow. In this review, we consider molecular mechanisms underlying this phenomenon and its importance in the context of solid tumor development. We have analyzed survival strategies of tumor cells using vasculogenic mimicry and described potential therapeutic approaches aimed at tumor growth and metastasis suppression. Highlighting the methods of histological and molecular identification of vasculogenic mimicry promotes better understanding of this phenomenon and its early diagnosis. The review focuses on the necessity of further research in the area of vasculogenic mimicry to conceptualize mechanisms underlying carcinogenesis. We have analyzed 109 articles from the leading biomedical databases including SciVerse Scopus, PubMed, Web of Science and RSCI (Russian Science Citation Index) which allowed us to summarize current scientific data and identify the key trends in the area of molecular oncology.
- 15 January 2025
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 12 (1) , 14-30
Open AccessThe balance between deception and adaptation: vasculogenic mimicry as a tumor survival strategy
Vasculogenic mimicry is a unique process through which tumor cells imitate normal vascular endothelial cells to secure access to the blood flow. In this review, we consider molecular mechanisms underlying this phenomenon and its importance in the context of solid tumor development. We have analyzed survival strategies of tumor cells using vasculogenic mimicry and described potential therapeutic approaches aimed at tumor growth and metastasis suppression. Highlighting the methods of histological and molecular identification of vasculogenic mimicry promotes better understanding of this phenomenon and its early diagnosis. The review focuses on the necessity of further research in the area of vasculogenic mimicry to conceptualize mechanisms underlying carcinogenesis. We have analyzed 109 articles from the leading biomedical databases including SciVerse Scopus, PubMed, Web of Science and RSCI (Russian Science Citation Index) which allowed us to summarize current scientific data and identify the key trends in the area of molecular oncology.